[HTML][HTML] The Introduction of Magtrace® Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial …

CY Kong, J Williams, N Hemadasa, D Murphy… - Clinical Breast …, 2024 - Elsevier
Background Magtrace is a supraparamagnetic iron lymphatic tracer that has had increasing
use in sentinel node biopsy (SNB) for breast cancer and has theoretical logistical benefits in …

[PDF][PDF] Evolution of sentinel lymph node biopsy for breast cancer patients in a rural setting: 10 years' experience

AWK Lau, VL Lau, MM Sakowska - The New Zealand Medical Journal …, 2023 - nzmj.org.nz
Sentinel lymph node (SLN) biopsy is the standard axillary staging procedure of early breast
cancer. Superparamagnetic iron oxide (SPIO) nanoparticles have been found to be …

Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis

E Pantiora, MK Tasoulis, A Valachis… - British Journal of …, 2023 - academic.oup.com
Background Superparamagnetic iron oxide nanoparticles (SPIO) have been used as a
tracer for sentinel lymph node (SLN) localization in breast cancer, demonstrating …

Assessing the Sentimag system for guiding sentinel node biopsies in patients with breast cancer

H Abidi, RJ Bold - Expert Review of Medical Devices, 2024 - Taylor & Francis
Introduction Sentinel lymph node biopsy for breast cancer is a method to localize and excise
the first draining lymph node from an invasive cancer of the breast. The histopathologic …

Injection of radioactive colloid and blue dye at the peri-areolar edge in the tumor quadrant for sentinel lymph node biopsy in breast cancer: Results of the UK NEW …

A Goyal, F MacNeill, M Keshtgar, K Horgan… - Journal of Clinical …, 2008 - ascopubs.org
538 Background: Despite the widespread application of sentinel lymph node biopsy (SLNB)
for early stage breast cancer, there is a wide variation in reported test performance …

The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment

M Ghilli, E Carretta, F Di Filippo… - European journal of …, 2017 - Wiley Online Library
The European Union has determined that from 2016 breast cancer patients should be
treated in Specialist Breast Units that achieve the minimum standards for the mandatory …

Optimizing dose and timing in magnetic tracer techniques for sentinel lymph node detection in early breast cancers: the prospective multicenter SentiDose trial

AF Hersi, L Pistiolis, C Dussan Luberth, E Vikhe-Patil… - Cancers, 2021 - mdpi.com
Simple Summary Superparamagnetic iron oxide (SPIO) nanoparticles have comparable
performance to the combination of radioisotope and blue dye (RI+ BD) for sentinel lymph …

Validation of lymphatic mapping and sentinel node biopsy in patients with symptomatic breast cancer

RA Cahill, L Diamond, R Landers, D Walsh… - Irish journal of medical …, 2006 - Springer
Background Lymphatic mapping and sentinel node biopsy in breast cancer aims to allow
lymph node negative women to avoid axillary clearance by providing a minimally invasive …

Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study)

R Vidya, M Khosla, S Laws, J Harvey, M Kaushik… - The Surgeon, 2023 - Elsevier
Abstract Background & Objectives Sentinel lymph node biopsy (SLNB) is an accurate and
reliable method for staging the axilla in early breast cancer. The gold standard technique for …

Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: a comparative non-inferiority study

A Piñero-Madrona, JA Torró-Richart… - European Journal of …, 2015 - Elsevier
Aims The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …